EichorEICHOR
Study identifier: NCT06163781 Synced from ClinicalTrials.gov · August 08, 2026
● Study status: RecruitingABC

Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning

Condition: Artificial Intelligence · Machine Learning · Microbiology  ·  Sponsor: Amsterdam UMC, location VUmc

PhaseNA
Planned participants7584
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYesCheck eligibility criteria ↓
WhereAmsterdam, Netherlands

Interested? Contact the study team ↓

Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.

About this study

The goal of this clinical trial is to study whether the use of our blood culture prediction tool is non-inferior to current practice and if it can improve certain outcomes in all adult patients presenting to the emergency department with a clinical indication for a blood culture analysis (according to the treating physician). The primary endpoint is 30-day mortality. Key secondary outcomes are: * hospital admission rates * in-hospital mortality * hospital length-of-stay. In the intervention group, the physician will follow the advice of our blood culture prediction tool. In the comparison group all patients will undergo a blood culture analysis.

This description comes directly from the study's public registry record.

Talk to the study team

Prabath WB Nanayakkara, MD, PhD  ·  +31204444444  ·  p.nanayakkara@amsterdamumc.nl

Sheena C Bhagirath, MD  ·  +31204444444  ·  s.bhagirath@amsterdamumc.nl

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Inclusion Criteria: * Age \>= 18 years * Have a clinical indication for a blood culture analysis (according to the treating physician) * Have sufficient data recorded (laboratory results and vital sign measurements) for a prediction to be made (at least 20% of the needed parameters) Exclusion Criteria: * Central Venous Line (CVL) or Peripherally Inserted Central Catheter (PICC) in situ * Neutrophil count \< 0.5 \* 109/L * Candidemia or S. aureus bacteraemia in the past 3 months. * Most likely diagnosis of endocarditis/spondylodiscitis/infected prosthetic material * Pregnant or breastfeeding patients * Not capable of giving informed consent

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (1)

Amsterdam UMC - location AMCAmsterdam, NetherlandsRecruiting

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

Amsterdam

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →